Using DUR And DUE Program To Evaluate The Drug Treatment In Patients With Malignant Lymphoma

Drugs are important materials to cure illness and defend disease. The reasonable utilization of drugs is related to people health level, even to social development level. Therefore, guided by modern, systemic, synthetic medicine treatment attain safe, valid and economic basic request. It's the first time to consider the necessity of developing large-scale drug utilization study in WHO poison academic association argument in 1964. The conception of drug utilization review was put forward in 1970～1980s. Furthermore, at present the ASHP puts forward again the drug utilization evaluation, which focuses on the reasonable utilization of drugs and qualitative and quantitative evaluation for the reasonability of the whole procedure of using medicine with the prescription, dispensing, supply and intake of medicine. The purpose of this research is to establish the reasonable, safe and efficient quality guarantee system of drug utilization. The drug utilization studies are limited by consumption of new arrival drugs consumption, and institutional reformation in hygiene medical treatment, the drug utilization research gets social widespread concern. In recent years, the DUR is launched at hospitals gradually, but The DUE is at elementary phase.THE PURPOSE: The purpose of this research is to study the characteristics and regulation of medicine curing malignant lymphoma, learn its present medicine treatment condition, trend and distribution in clinical treatment through the DUR study. And via the DUE study in the same specimen, learn the diagnose and treat status, analysis and appraise the drug use with reason, and put forward the suggest. Using DUR and DUE program to evaluate the drug treatment in patients with malignant lymphoma. To develope drug use criteria which could be applied to the hospital affiliated to bengbu medical college for evaluating the drug treatment in...